Related to other eukaryotic COPII adaptors. Likely involved in ER to Golgi transport.. A Leishmaniid-specific subgroup of these proteins is missing the SigP (unclear topology and function). Localization: ER (by homology) / Golgi (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | yes | yes: 13, no: 7 |
NetGPI | no | yes: 0, no: 20 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005783 | endoplasmic reticulum | 5 | 3 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 5 | 3 |
GO:0005794 | Golgi apparatus | 5 | 3 |
GO:0016020 | membrane | 2 | 21 |
GO:0030134 | COPII-coated ER to Golgi transport vesicle | 8 | 3 |
GO:0030135 | coated vesicle | 7 | 3 |
GO:0031410 | cytoplasmic vesicle | 6 | 3 |
GO:0031982 | vesicle | 4 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0097708 | intracellular vesicle | 5 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 21 |
Related structures:
AlphaFold database: Q4Q6F2
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 3 |
GO:0006886 | intracellular protein transport | 4 | 3 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | 3 |
GO:0006996 | organelle organization | 4 | 3 |
GO:0007030 | Golgi organization | 5 | 3 |
GO:0008104 | protein localization | 4 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0015031 | protein transport | 4 | 3 |
GO:0016043 | cellular component organization | 3 | 3 |
GO:0016192 | vesicle-mediated transport | 4 | 3 |
GO:0033036 | macromolecule localization | 2 | 3 |
GO:0045184 | establishment of protein localization | 3 | 3 |
GO:0046907 | intracellular transport | 3 | 3 |
GO:0048193 | Golgi vesicle transport | 5 | 3 |
GO:0051179 | localization | 1 | 3 |
GO:0051234 | establishment of localization | 2 | 3 |
GO:0051641 | cellular localization | 2 | 3 |
GO:0051649 | establishment of localization in cell | 3 | 3 |
GO:0070727 | cellular macromolecule localization | 3 | 3 |
GO:0071702 | organic substance transport | 4 | 3 |
GO:0071705 | nitrogen compound transport | 4 | 3 |
GO:0071840 | cellular component organization or biogenesis | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.264 |
CLV_PCSK_KEX2_1 | 206 | 208 | PF00082 | 0.255 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.398 |
CLV_PCSK_SKI1_1 | 206 | 210 | PF00082 | 0.206 |
DEG_APCC_DBOX_1 | 181 | 189 | PF00400 | 0.171 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.691 |
DOC_CYCLIN_RxL_1 | 203 | 213 | PF00134 | 0.297 |
DOC_MAPK_gen_1 | 102 | 110 | PF00069 | 0.312 |
DOC_MAPK_MEF2A_6 | 102 | 110 | PF00069 | 0.203 |
DOC_MAPK_MEF2A_6 | 18 | 25 | PF00069 | 0.492 |
DOC_PP1_RVXF_1 | 118 | 125 | PF00149 | 0.227 |
DOC_PP1_RVXF_1 | 180 | 187 | PF00149 | 0.253 |
DOC_PP1_RVXF_1 | 55 | 62 | PF00149 | 0.291 |
DOC_PP1_RVXF_1 | 86 | 93 | PF00149 | 0.358 |
DOC_PP4_FxxP_1 | 95 | 98 | PF00568 | 0.333 |
LIG_14-3-3_CanoR_1 | 127 | 131 | PF00244 | 0.318 |
LIG_APCC_ABBA_1 | 63 | 68 | PF00400 | 0.301 |
LIG_BRCT_BRCA1_1 | 25 | 29 | PF00533 | 0.586 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.258 |
LIG_FHA_1 | 36 | 42 | PF00498 | 0.299 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.270 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.258 |
LIG_LIR_Apic_2 | 68 | 72 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 187 | 197 | PF02991 | 0.311 |
LIG_LIR_Gen_1 | 199 | 208 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 26 | 37 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 187 | 192 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.289 |
LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.210 |
LIG_LIR_Nem_3 | 89 | 95 | PF02991 | 0.289 |
LIG_NRBOX | 204 | 210 | PF00104 | 0.469 |
LIG_PDZ_Class_1 | 210 | 215 | PF00595 | 0.534 |
LIG_SH2_STAP1 | 134 | 138 | PF00017 | 0.276 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.322 |
LIG_Sin3_3 | 29 | 36 | PF02671 | 0.431 |
LIG_SUMO_SIM_par_1 | 194 | 199 | PF11976 | 0.378 |
LIG_SUMO_SIM_par_1 | 71 | 77 | PF11976 | 0.274 |
LIG_TRFH_1 | 63 | 67 | PF08558 | 0.301 |
LIG_UBA3_1 | 204 | 212 | PF00899 | 0.468 |
LIG_WRC_WIRS_1 | 107 | 112 | PF05994 | 0.339 |
LIG_WRC_WIRS_1 | 197 | 202 | PF05994 | 0.341 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.269 |
MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.521 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.505 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.649 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.667 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.669 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.313 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.297 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.425 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.464 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.695 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.273 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.276 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.275 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.282 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.228 |
MOD_NEK2_1 | 184 | 189 | PF00069 | 0.293 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.450 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.312 |
MOD_PKA_2 | 172 | 178 | PF00069 | 0.243 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.283 |
MOD_Plk_4 | 112 | 118 | PF00069 | 0.304 |
MOD_SUMO_rev_2 | 142 | 148 | PF00179 | 0.288 |
TRG_DiLeu_BaLyEn_6 | 15 | 20 | PF01217 | 0.519 |
TRG_DiLeu_BaLyEn_6 | 204 | 209 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.289 |
TRG_ER_diArg_1 | 205 | 207 | PF00400 | 0.455 |
TRG_ER_diLys_1 | 211 | 215 | PF00400 | 0.667 |
TRG_Pf-PMV_PEXEL_1 | 206 | 210 | PF00026 | 0.247 |
TRG_Pf-PMV_PEXEL_1 | 57 | 62 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZG2 | Leptomonas seymouri | 25% | 99% |
A0A0N1I2E2 | Leptomonas seymouri | 59% | 100% |
A0A0N1II77 | Leptomonas seymouri | 44% | 100% |
A0A0N1PA81 | Leptomonas seymouri | 42% | 100% |
A0A0S4JG68 | Bodo saltans | 34% | 97% |
A0A0S4JHA6 | Bodo saltans | 34% | 100% |
A0A1X0NKZ3 | Trypanosomatidae | 34% | 97% |
A0A3R7KJS3 | Trypanosoma rangeli | 32% | 99% |
A0A3S7X4D1 | Leishmania donovani | 41% | 66% |
A0A3S7X4G7 | Leishmania donovani | 92% | 100% |
A4HJ91 | Leishmania braziliensis | 68% | 100% |
A4HJ92 | Leishmania braziliensis | 43% | 100% |
A4I6N5 | Leishmania infantum | 92% | 100% |
A4I6N6 | Leishmania infantum | 41% | 100% |
C9ZM72 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
C9ZWV3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
E9B1Q8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
E9B1Q9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 40% | 100% |
Q4Q6F1 | Leishmania major | 40% | 100% |
Q90515 | Takifugu rubripes | 28% | 100% |
Q9P7I9 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 100% |
V5BK13 | Trypanosoma cruzi | 35% | 97% |